tradmap

CARL Earnings CARLSMED, INC.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$6 -$3 $0 2024 2025
EPS
Revenue (annual)
$0 $25M $51M 2024 2025
Revenue
Net income (annual)
-$30M -$15M $0 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$5 -$2 $0 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26
EPS
Revenue (quarterly)
$0 $9M $19M Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue
Net income (quarterly)
-$11M -$5M $0 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Net income

Reported EPS history

1–9 of 9
Q2 20262026-06-30-0.712026-08-0510-Q
Q1 20262026-03-31-0.322026-05-0510-Q
FY 20252025-12-31-2.122026-02-2510-K
Q3 20252025-09-30-2.152025-11-0610-Q
Q2 20262025-06-30-2.942026-08-0510-Q
Q1 20262025-03-31-1.472026-05-0510-Q
FY 20252024-12-31-6.112026-02-2510-K
Q3 20252024-09-30-4.972025-11-0610-Q
Q2 20252024-06-30-2.912025-08-2810-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.